Legend Biotech Corporation (NASDAQ:LEGN) Q1 2025 Earnings Call Transcript

Legend Biotech Corporation (NASDAQ:LEGN) Q1 2025 Earnings Call Transcript May 13, 2025

Legend Biotech Corporation beats earnings expectations. Reported EPS is $-0.07, expectations were $-0.4.

Operator: Good day, and thank you for standing by. Welcome to the Legend Biotech’s First Quarter 2025 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that...